Bristol-Myers has agreed to pay $85 million upfront to ZymoGenetics for rights to PEG-Interferon lambda and will pay another $20 million license fee to ZymoGenetics in 2009, the companies announced Monday.
More: continued here
Bristol-Myers has agreed to pay $85 million upfront to ZymoGenetics for rights to PEG-Interferon lambda and will pay another $20 million license fee to ZymoGenetics in 2009, the companies announced Monday.
More: continued here